Shire, ANI Pharmaceuticals deal

Shire sold ANI U.S. rights to 125 and 250 mg Vancocin vancomycin capsules for Clostridium difficile-associated diarrhea (CDAD) and approved ANDAs for 500 mg, 1 g and 10 g injectable and 250 and 500 m...